This IDC Survey Spotlight analyzes data covering the European life sciences industry from the Global IoT Decision Maker Survey, 2019 — a global landmark study of Internet of Things (IoT) ecosystems, strategies, investment priorities, and emerging trends. The European life sciences sample consisted of 160 (81 pharmaceutical and 79 biotech) organizations with more than 100 employees.
"IoT is the key technology pillar of the new digital platform for life sciences. As the European life sciences industry moves forward with the adoption of transformative technologies, the focus on IoT is sharpening. IoT is at the core of digital innovation efforts to transform life sciences supply chain operations and strengthen customer and patient engagement and experience, while ensuring regulatory compliance." — Senior Research Analyst Nino Giguashvili, IDC Health Insights EMEA